Tandem Diabetes Care (TNDM) EBIT Margin Growth (5y) (2018 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EBIT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn |
| 3 | Medtronic | 117.17 Bn | 108.35 Bn | 6.34 Bn |
| 4 | Stryker | 104.15 Bn | 100.67 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.37 Bn | 62.83 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.16 Bn | 30.22 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 806.56 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -857.00 |
| Mar 31, 2026 | -476.00 |
| Dec 31, 2025 | -825.00 |
| Sep 30, 2025 | -836.00 |
| Jun 30, 2025 | -1,051.00 |
| Mar 31, 2025 | -3,770.00 |
| Dec 31, 2024 | -218.00 |
| Sep 30, 2024 | -435.00 |
| Jun 30, 2024 | -1,187.00 |
| Mar 31, 2024 | -508.00 |
| Dec 31, 2023 | -1,855.00 |
| Sep 30, 2023 | 1,696.00 |
| Jun 30, 2023 | 2,121.00 |
| Mar 31, 2023 | -1,869.00 |
| Dec 31, 2022 | 1,572.00 |
| Sep 30, 2022 | 2,554.00 |
| Jun 30, 2022 | 8,283.00 |
| Mar 31, 2022 | 10,313.00 |
| Dec 31, 2021 | 5,223.00 |
| Sep 30, 2021 | 23,544.00 |